Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples